Page last updated: 2024-08-25

drospirenone and Cardiovascular Diseases

drospirenone has been researched along with Cardiovascular Diseases in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (29.17)29.6817
2010's15 (62.50)24.3611
2020's2 (8.33)2.80

Authors

AuthorsStudies
Dožić, B; Dožić, I; Srebro, D; Vujović, S; Đogo, A1
Colli, E; Palacios, S; Regidor, PA1
Bodur, S; Dundar, O; Kanat-Pektas, M; Kinci, MF; Tutuncu, L1
Ambrosio, D; Cerreto, FV; De Franciscis, P; Labriola, D; Leo, S; Luisi, A; Mainini, G; Russo, C; Santangelo, F; Torella, M1
Bajuk Studen, K; Jensterle Sever, M; Pfeifer, M1
El-Haggar, SM; Mostafa, TM1
Dinger, J; Heinemann, K; Möhner, S1
Bardenheuer, K; Dinger, J; Heinemann, K1
Bottiglieri, P; Colao, A; Colarieti, G; Giallauria, F; Muscogiuri, G; Orio, F; Palomba, S; Predotti, P; Savastano, S; Tafuri, D1
Fini, M; Gambacciani, M; Mammi, C; Rosano, GMC; Russo, N; Spoletini, I; Vitale, C; Volterrani, M1
Battaglia, C; Busacchi, P; Cianciosi, A; Facchinetti, F; Mancini, F; Persico, N1
Assmann, A; Bardenheuer, K; Dinger, JC1
Fruzzetti, F; Gambacciani, M; Genazzani, AR; Lazzarini, V; Parrini, D; Perini, D1
Genazzani, AR; Simoncini, T1
Boschitsch, E; Magometschnigg, D; Mayerhofer, S1
Arslanian, S; Lee, S; Sutton-Tyrrell, K; Tfayli, H; Ulnach, JW1
Cremer, M; Friedman, J; Huang, X; Jelani, QU; Jian, J; Katz, SD; Shah, S1
Arangino, S; Cagnacci, A; Ferrari, S; Napolitano, A; Piacenti, I; Volpe, A1
He, FJ; MacGregor, GA1
Christiansen, C; Tankó, LB1
Tsuda, K1
Marazzi, G; Rosano, GM; Vitale, C; Volterrani, M1
Motivala, A; Pitt, B1
Skouby, SO1

Reviews

7 review(s) available for drospirenone and Cardiovascular Diseases

ArticleYear
Cardiovascular risk and subclinical cardiovascular disease in polycystic ovary syndrome.
    Frontiers of hormone research, 2013, Volume: 40

    Topics: Adolescent; Adult; Androstenes; Atherosclerosis; Cardiovascular Diseases; Carotid Intima-Media Thickness; Coronary Artery Disease; Female; Humans; Hypertension; Incretins; Insulin Resistance; Life Style; Metformin; Middle Aged; Obesity; Polycystic Ovary Syndrome; Postmenopause; Renin-Angiotensin System; Risk Factors; Sleep Apnea, Obstructive; Thiazolidinediones; Vascular Stiffness; Weight Reduction Programs

2013
A review of the cardiovascular and breast actions of drospirenone in preclinical studies.
    Climacteric : the journal of the International Menopause Society, 2010, Volume: 13, Issue:1

    Topics: Androstenes; Animals; Breast; Breast Neoplasms; Cardiovascular Diseases; Cardiovascular System; Estrogen Replacement Therapy; Estrogens; Female; Humans; Menopause; Mineralocorticoid Receptor Antagonists; Progesterone Congeners; Progestins; Risk Factors

2010
Hypertension in women: the role of progesterone and aldosterone.
    Climacteric : the journal of the International Menopause Society, 2010, Volume: 13, Issue:4

    Topics: Aged; Aldosterone; Androstenes; Animals; Cardiovascular Diseases; Diet, Sodium-Restricted; Estradiol; Estrogens; Female; Humans; Hypertension; Middle Aged; Mineralocorticoid Receptor Antagonists; Natriuresis; Progesterone; Progesterone Congeners; Renin-Angiotensin System; Risk Factors; Sex Characteristics

2010
Importance of controlling blood pressure.
    Climacteric : the journal of the International Menopause Society, 2005, Volume: 8 Suppl 3

    Topics: Androstenes; Antihypertensive Agents; Cardiovascular Diseases; Clinical Trials as Topic; Diet, Sodium-Restricted; Humans; Hypertension; Mineralocorticoid Receptor Antagonists; Progesterone Congeners; Risk Factors; Sodium Chloride, Dietary

2005
Menopause and cardiovascular disease: the evidence.
    Climacteric : the journal of the International Menopause Society, 2007, Volume: 10 Suppl 1

    Topics: Androstenes; Cardiovascular Diseases; Diabetes Mellitus; Estrogen Replacement Therapy; Female; Humans; Hypertension; Menopause; Mineralocorticoid Receptor Antagonists; Risk Factors; Weight Gain

2007
Drospirenone for oral contraception and hormone replacement therapy: are its cardiovascular risks and benefits the same as other progestogens?
    Drugs, 2007, Volume: 67, Issue:5

    Topics: Androstenes; Cardiovascular Diseases; Contraceptives, Oral; Hormone Replacement Therapy; Humans; Mineralocorticoid Receptor Antagonists; Progestins; Risk Assessment

2007
The rationale for a wider range of progestogens.
    Climacteric : the journal of the International Menopause Society, 2000, Volume: 3 Suppl 2

    Topics: Androstenes; Biological Availability; Breast Neoplasms; Cardiovascular Diseases; Contraindications; Endometrial Neoplasms; Estranes; Estrogen Replacement Therapy; Female; Gonanes; Humans; Nandrolone; Osteoporosis, Postmenopausal; Pregnanes; Primary Prevention; Progestins; Treatment Outcome

2000

Trials

8 trial(s) available for drospirenone and Cardiovascular Diseases

ArticleYear
Efficacy and cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24/4 regime.
    BMC women's health, 2020, 10-02, Volume: 20, Issue:1

    Topics: Adult; Androstenes; Blood Pressure; Cardiovascular Diseases; Contraception; Female; Humans; Middle Aged; Mineralocorticoid Receptor Antagonists

2020
The effects of different therapeutic modalities on cardiovascular risk factors in women with polycystıc ovary syndrome: A randomızed controlled study.
    Taiwanese journal of obstetrics & gynecology, 2018, Volume: 57, Issue:3

    Topics: Adult; Androstenes; Apolipoproteins B; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Drug Therapy, Combination; Ethinyl Estradiol; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Metabolic Syndrome; Metformin; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Reproductive Control Agents; Risk Factors; Young Adult

2018
Drospirenone plus estradiol and the risk of serious cardiovascular events in postmenopausal women.
    Climacteric : the journal of the International Menopause Society, 2016, Volume: 19, Issue:4

    Topics: Androstenes; Antihypertensive Agents; Cardiovascular Diseases; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Follow-Up Studies; Humans; Incidence; Middle Aged; Mineralocorticoid Receptor Antagonists; Postmenopause; Proportional Hazards Models; Prospective Studies; Regression Analysis; Risk Factors; Single-Blind Method; Thromboembolism

2016
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial.
    Clinical endocrinology, 2016, Volume: 85, Issue:5

    Topics: Adult; Androstenes; Cardiovascular Diseases; Carotid Intima-Media Thickness; Contraceptives, Oral; Ethinyl Estradiol; Exercise; Female; Humans; Hyperandrogenism; Metabolic Diseases; Polycystic Ovary Syndrome; Risk Factors; Young Adult

2016
Effect of hormone replacement therapy with the anti-mineralocorticoid progestin Drospirenone compared to tibolone on endothelial function and central haemodynamics in post-menopausal women.
    International journal of cardiology, 2017, Jan-15, Volume: 227

    Topics: Androstenes; Blood Pressure Determination; Cardiovascular Diseases; Cells, Cultured; Double-Blind Method; Drug Combinations; Endothelial Cells; Endothelium, Vascular; Estradiol; Female; Hemodynamics; Hormone Replacement Therapy; Humans; Hypertension; Middle Aged; Mineralocorticoid Receptor Antagonists; Norpregnenes; Postmenopause; Progestins; Pulse Wave Analysis; Reference Values; Treatment Outcome

2017
Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
    Fertility and sterility, 2010, Volume: 94, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Androgens; Androstenes; Blood Pressure; Cardiovascular Diseases; Cyproterone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Glucose; Humans; Hypoglycemic Agents; Insulin; Lipids; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Risk Factors; Young Adult

2010
Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors.
    The Journal of clinical endocrinology and metabolism, 2011, Volume: 96, Issue:5

    Topics: Adolescent; Adrenocorticotropic Hormone; Androstenes; Body Composition; Cardiovascular Diseases; Double-Blind Method; Ethinyl Estradiol; Female; Glucose Clamp Technique; Glucose Tolerance Test; Hemodynamics; Hormones; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Overweight; Polycystic Ovary Syndrome; Risk Factors; Rosiglitazone; Stimulation, Chemical; Thiazolidinediones

2011
Effects of 17beta-oestradiol plus different doses of drospirenone on adipose tissue, adiponectin and atherogenic metabolites in postmenopausal women.
    Journal of internal medicine, 2005, Volume: 258, Issue:6

    Topics: Absorptiometry, Photon; Adiponectin; Adipose Tissue; Aged; Androstenes; Blood Pressure; Cardiovascular Diseases; Cholesterol, HDL; Double-Blind Method; Drug Therapy, Combination; Estradiol; Female; Humans; Interleukin-6; Middle Aged; Mineralocorticoid Receptor Antagonists; Postmenopause; Risk Factors; Triglycerides

2005

Other Studies

9 other study(ies) available for drospirenone and Cardiovascular Diseases

ArticleYear
Effects of continuous-combined oral drospirenone- estradiol on blood pressure, body weight & lipid profile in early menopausal women.
    The Indian journal of medical research, 2021, Volume: 154, Issue:6

    Topics: Adult; Androstenes; Blood Pressure; Body Weight; Cardiovascular Diseases; Cholesterol; Estradiol; Female; Humans; Hypertension; Lipids; Menopause; Menopause, Premature; Middle Aged; Retrospective Studies

2021
Low-dose estrogen and drospirenone combination: effects on metabolism and endothelial function in postmenopausal women with metabolic syndrome.
    Clinical and experimental obstetrics & gynecology, 2013, Volume: 40, Issue:2

    Topics: Androstenes; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Carotid Artery, Common; Carotid Intima-Media Thickness; Cholesterol; Endothelium, Vascular; Estrogens; Ethinyl Estradiol; Female; Humans; Metabolic Syndrome; Middle Aged; Postmenopause; Risk Factors; Triglycerides; Vasodilation

2013
Cardiovascular risk in Egyptian healthy consumers of different types of combined oral contraceptives pills: A comparative study.
    Endocrine, 2015, Volume: 49, Issue:3

    Topics: Adiponectin; Adipose Tissue; Adult; Androstenes; Anthropometry; Cardiovascular Diseases; Chemistry, Pharmaceutical; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Cross-Sectional Studies; Drug Combinations; Egypt; Ethinyl Estradiol; Female; Humans; Leptin; Levonorgestrel; Norpregnenes; Resistin; Risk Factors

2015
Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptives.
    Contraception, 2016, Volume: 93, Issue:5

    Topics: Adult; Androstenes; Cardiovascular Diseases; Cohort Studies; Contraceptives, Oral, Combined; Ethinyl Estradiol; Europe; Female; Follow-Up Studies; Humans; Incidence; Levonorgestrel; Longitudinal Studies; Mineralocorticoid Receptor Antagonists; Patient Reported Outcome Measures; Pharmacovigilance; Progestins; Proportional Hazards Models; Risk Factors

2016
Drospirenone and cardiovascular risk in lean and obese polycystic ovary syndrome patients: a pilot study.
    American journal of obstetrics and gynecology, 2010, Volume: 202, Issue:2

    Topics: Adolescent; Adult; Androstenes; Brachial Artery; Cardiovascular Diseases; Contraceptives, Oral; Endothelin-1; Female; Homocysteine; Humans; Insulin; Insulin Resistance; Leptin; Mineralocorticoid Receptor Antagonists; Obesity; Pilot Projects; Polycystic Ovary Syndrome

2010
International Active Surveillance Study of Women Taking Oral Contraceptives (INAS-OC Study).
    BMC medical research methodology, 2009, Nov-18, Volume: 9

    Topics: Adolescent; Adult; Androstenes; Cardiovascular Diseases; Cohort Studies; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Internationality; Population Surveillance; Progestins; Research Design; Young Adult

2009
Oral contraceptive use, iron stores and vascular endothelial function in healthy women.
    Contraception, 2011, Volume: 84, Issue:3

    Topics: Adult; Androstenes; Blood Flow Velocity; Brachial Artery; Cardiovascular Diseases; Contraceptives, Oral; Cross-Sectional Studies; Endothelium, Vascular; Estranes; Female; Ferritins; Gonanes; Humans; Iron; Linear Models; Ultrasonography; Vasodilation; Young Adult

2011
Combined oral contraceptive containing drospirenone does not modify 24-h ambulatory blood pressure but increases heart rate in healthy young women: prospective study.
    Contraception, 2013, Volume: 88, Issue:3

    Topics: Adolescent; Adult; Androstenes; Blood Pressure; Cardiovascular Diseases; Circadian Rhythm; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Heart Rate; Humans; Hypertension; Young Adult

2013
A new hormone therapy with drospirenone and NO production in postmenopausal women.
    Hypertension (Dallas, Tex. : 1979), 2006, Volume: 48, Issue:5

    Topics: Androstenes; Animals; Antihypertensive Agents; Cardiovascular Diseases; Estradiol; Humans; Mineralocorticoid Receptor Antagonists; Nitric Oxide; Postmenopause

2006